These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 23043941

  • 1. Development of foot-and-mouth disease virus (FMDV) serotype O virus-like-particles (VLPs) vaccine and evaluation of its potency.
    Mohana Subramanian B, Madhanmohan M, Sriraman R, Chandrasekhar Reddy RV, Yuvaraj S, Manikumar K, Rajalakshmi S, Nagendrakumar SB, Rana SK, Srinivasan VA.
    Antiviral Res; 2012 Dec; 96(3):288-95. PubMed ID: 23043941
    [Abstract] [Full Text] [Related]

  • 2. Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge.
    Bhat SA, Saravanan P, Hosamani M, Basagoudanavar SH, Sreenivasa BP, Tamilselvan RP, Venkataramanan R.
    Res Vet Sci; 2013 Dec; 95(3):1217-23. PubMed ID: 23969204
    [Abstract] [Full Text] [Related]

  • 3. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
    Veerapen VP, van Zyl AR, Wigdorovitz A, Rybicki EP, Meyers AE.
    Virus Res; 2018 Jan 15; 244():213-217. PubMed ID: 29196195
    [Abstract] [Full Text] [Related]

  • 4. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus.
    Zheng M, Jin N, Zhang H, Jin M, Lu H, Ma M, Li C, Yin G, Wang R, Liu Q.
    J Virol Methods; 2006 Sep 15; 136(1-2):230-7. PubMed ID: 16780963
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine.
    Barrera J, Schutta C, Pisano M, Grubman MJ, Brake DA, Miller T, Kamicker BJ, Olutunmbi F, Ettyreddy D, Brough DE, Butman BT, Neilan JG.
    Vaccine; 2018 Feb 14; 36(8):1078-1084. PubMed ID: 29358056
    [Abstract] [Full Text] [Related]

  • 7. Comparative efficacy of virus like particle (VLP) vaccine of foot-and-mouth-disease virus (FMDV) type O adjuvanted with poly I:C or CpG in guinea pigs.
    Terhuja M, Saravanan P, Tamilselvan RP.
    Biologicals; 2015 Nov 14; 43(6):437-43. PubMed ID: 26493006
    [Abstract] [Full Text] [Related]

  • 8. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle.
    Sreenivasa BP, Mohapatra JK, Pauszek SJ, Koster M, Dhanya VC, Tamil Selvan RP, Hosamani M, Saravanan P, Basagoudanavar SH, de Los Santos T, Venkataramanan R, Rodriguez LL, Grubman MJ.
    Vet Microbiol; 2017 May 14; 203():196-201. PubMed ID: 28619144
    [Abstract] [Full Text] [Related]

  • 9. Immunogenicity of plasmids encoding P12A and 3C of FMDV and swine IL-18.
    Mingxiao M, Ningyi J, Juan LH, Min Z, Guoshun S, Guangze Z, Huijun L, Xiaowei H, Minglan J, Xu L, Haili M, Yue J, Gefen Y, Kuoshi J.
    Antiviral Res; 2007 Oct 14; 76(1):59-67. PubMed ID: 17606304
    [Abstract] [Full Text] [Related]

  • 10. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
    Moraes MP, Segundo FD, Dias CC, Pena L, Grubman MJ.
    Vaccine; 2011 Nov 28; 29(51):9431-40. PubMed ID: 22027486
    [Abstract] [Full Text] [Related]

  • 11. Development of a liquid-phase blocking ELISA based on foot-and-mouth disease virus empty capsid antigen for seromonitoring vaccinated animals.
    Basagoudanavar SH, Hosamani M, Tamil Selvan RP, Sreenivasa BP, Saravanan P, Chandrasekhar Sagar BK, Venkataramanan R.
    Arch Virol; 2013 May 28; 158(5):993-1001. PubMed ID: 23242775
    [Abstract] [Full Text] [Related]

  • 12. Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.
    Capozzo AV, Wilda M, Bucafusco D, de los Ángeles Lavoria M, Franco-Mahecha OL, Mansilla FC, Pérez-Filgueira DM, Grigera PR.
    Antiviral Res; 2011 Nov 28; 92(2):219-27. PubMed ID: 21889542
    [Abstract] [Full Text] [Related]

  • 13. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
    Foord AJ, Muller JD, Yu M, Wang LF, Heine HG.
    J Immunol Methods; 2007 Apr 10; 321(1-2):142-51. PubMed ID: 17328909
    [Abstract] [Full Text] [Related]

  • 14. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
    Mayr GA, Chinsangaram J, Grubman MJ.
    Virology; 1999 Oct 25; 263(2):496-506. PubMed ID: 10544121
    [Abstract] [Full Text] [Related]

  • 15. CpG oligodeoxynucleotide and montanide ISA 206 adjuvant combination augments the immune responses of a recombinant FMDV vaccine in cattle.
    Ren J, Yang L, Xu H, Zhang Y, Wan M, Liu G, Zhao L, Wang L, Yu Y.
    Vaccine; 2011 Oct 19; 29(45):7960-5. PubMed ID: 21872635
    [Abstract] [Full Text] [Related]

  • 16. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ.
    Biologicals; 2005 Dec 19; 33(4):227-34. PubMed ID: 16289996
    [Abstract] [Full Text] [Related]

  • 17. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
    Ren ZJ, Tian CJ, Zhu QS, Zhao MY, Xin AG, Nie WX, Ling SR, Zhu MW, Wu JY, Lan HY, Cao YC, Bi YZ.
    Vaccine; 2008 Mar 10; 26(11):1471-81. PubMed ID: 18289743
    [Abstract] [Full Text] [Related]

  • 18. Foot-and-Mouth Disease (FMD) Virus 3C Protease Mutant L127P: Implications for FMD Vaccine Development.
    Puckette M, Clark BA, Smith JD, Turecek T, Martel E, Gabbert L, Pisano M, Hurtle W, Pacheco JM, Barrera J, Neilan JG, Rasmussen M.
    J Virol; 2017 Nov 15; 91(22):. PubMed ID: 28878081
    [Abstract] [Full Text] [Related]

  • 19. Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine.
    Pena L, Moraes MP, Koster M, Burrage T, Pacheco JM, Segundo FD, Grubman MJ.
    Vaccine; 2008 Oct 23; 26(45):5689-99. PubMed ID: 18762225
    [Abstract] [Full Text] [Related]

  • 20. No significant differences in the breadth of the foot-and-mouth disease serotype A vaccine induced antibody responses in cattle, using different adjuvants, mixed antigens and different routes of administration.
    Tekleghiorghis T, Weerdmeester K, van Hemert-Kluitenberg F, Moormann RJ, Dekker A.
    Vaccine; 2014 Sep 15; 32(41):5330-6. PubMed ID: 25092634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.